Sequence variation within three important cytomegalovirus gene regions in isolates from four different patient populations

Journal of Clinical Microbiology

Volumn 36, Issue 12, 1998, Pages 3662-3669

  Zweygberg Wirgart, Benita ^a   Brytting, Maria ^b   Linde, Annika ^b   Wahren, Britta ^b   Grillner, Lena ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; GLYCOPROTEIN;

ARTICLE; CYTOMEGALOVIRUS; DAY CARE; DNA SEQUENCE; EARLY DIAGNOSIS; ENZYME ACTIVITY; EXON; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; VIRUS GENE; VIRUS ISOLATION; VIRUS TRANSMISSION;

CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; DNA VIRUSES; HUMAN HERPESVIRUS 5; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0344148904     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.36.12.3662-3669.1998     Document Type: Article

References (27)

1. Akrigg, A., G. W. G. Wilkinson, and J. D. Oram. 1985. The structure of the major immediate early gene of human cytomegalovirus strain Ad169. Virus Res. 2:107-121.
2. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus, p. 2493-2523. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
3. Brytting, M., J. Wahlberg, J. Lundberg, B. Wahren, M. Uhlen, and V.-A. Sundqvist. 1992. Variations in the cytomegalovirus major immediate-early gene found by direct genome sequencing. J. Clin. Microbiol. 30:955-960.
4. Cha, T.-A., E. Tom, G. W. Kemble, G. M. Duke, E. S. Mocarski, and R. R. Spaete. 1996. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J. Virol. 70:78-83.
5. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, E. Preddie, S. C. Satchwell, P. Tomlinson, K. M. Weston, and B. G. Barrell. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-170.
6. Chou, S. 1992. Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region. J. Clin. Microbiol. 30:2307-2310.
7. Chou, S. 1986. Acquisition of donor strains of cytomegalovirus by renal-transplant recipients. N. Engl. J. Med. 314:1418-1423.
8. Chou, S., and K. M. Dennison. 1991. Analysis of interstrain variation in cytomegalovirus glycoprotein B sequences encoding neutralization-related epitopes. J. Infect. Dis. 163:1229-1234.
9. Cranage, M. P., T. Kouzarides, A. T. Bankier, S. C. Satchwell, K. Weston, P. Tomlinson, B. G. Barrell, H. Hart, S. E. Bell, A. C. Minson, and G. L. Smith. 1986. Identification of the human cytomegalovirus glycoprotein B gene and induction of neutralizing antibodies via its expression in recombinant vaccinia virus. EMBO J. 5:3057-3063.
10. Darlington, J., M. Super, K. Patel, J. Grundy, P. Griffiths, and V. C. Emery. 1991. Use of the polymerase chain reaction to analyse sequence variation within a major neutralizing epitope of glycoprotein B (gp58) in clinical isolates of human cytomegalovirus. J. Gen. Virol. 72:1985-1989.
11. Gibbs, J. S., H. C. Chiou, K. F. Bastow, Y. C. Cheng, and D. M. Coen. 1988. Identification of amino acids in herpes simplex virus DNA polymerase involved in substrate and drug recognition. Proc. Natl. Acad. Sci. USA 85: 6672-6676.
12. Grillner, L., and K. A. Strangert. 1988. A prospective molecular epidemiological study of cytomegalovirus infection in two day-care centres in Sweden. No evidence for horizontal transmission within the centres. J. Infect. Dis. 157:1080-1083.
13. Ho, M. 1991. Cytomegalovirus: biology and infection, 2nd ed., p. 229-300. Plenum Medical Book Co., New York, N.Y.
14. Hwang, C. B., C., K. L. Ruffner, and D. M. Coen. 1992. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance. J. Virol. 66:1774-1776.
15. Ihara, S., M. Takekoshi, N. Mori, S. Sakuma, J. Hashimoto, and Y. Watanabe. 1994. Identification of mutation sites of a temperature-sensitive mutant of HCMV DNA polymerase activity. Arch. Virol. 137:263-275.
16. Kouzarides, T., A. T. Bankier, S. C. Satchwell, K. Weston, P. Tomlinson, and B. G. Barrell. 1987. Sequence and transcription analysis of the human cytomegalovirus DNA polymerase gene. J. Virol. 61:125-133.
17. Lehner, R., T. Stamminger, and M. Mach. 1991. Comparative sequence analysis of human cytomegalovirus strains. J. Clin. Microbiol. 29:2494-2502.
18. Lurain, N. S., K. D. Thompson, E. W. Holmes, and G. S. Read. 1992. Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J. Virol. 66:7146-7152.
19. Mocarski, E. S. 1996. Cytomegaloviruses and their replication, p. 2447-2492. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven, Philadelphia, Pa.
20. Spaete, R., R. M. Thayer, W. S. Probert, F. R. Masiarz, S. H. Chamberlain, L. Rasmussen, T. C. Merigan, and C. Pachl. 1988. Human cytomegalovirus strain Towne glycoprotein B is processed by proteolytic cleavage. Virology 167:207-225.
21. Tatti, K. M., I. L. Smith, and R. F. Schinazi. 1998. Mutations in human cytomegalovirus (HCMV) DNA polymerase associated with antiviral resistance. Int. Antivir. News 6:1.
22. Teo, I. A., B. E. Griffin, and M. D. Jones. 1991. Characterization of the DNA polymerase gene of human herpesvirus 6. J. Virol. 65:4670-4680.
23. Wagner, B., B. Kropff, H. Kalbacher, W. Britt, V.-A. Sundqvist, L. Östberg, and M. Mach. 1992. A continuous sequence of more than 70 amino acids is essential for antibody binding to the dominant antigenic site of glycoprotein gp58 of human cytomegalovirus. J. Virol. 66:5290-5297.
24. Wahlberg, J., J. Lundeberg, T. Hultman, and M. Uhlén. 1990. General colorimetric method for DNA diagnostics allowing direct solid phase genomic sequencing of the positive samples. Proc. Natl. Acad. Sci. USA 87: 6569-6573.
25. Winston, D. J. 1995. Prevention of cytomegalovirus disease in transplant recipients. Lancet 346:1380-1381.
26. Wong, S. W., A. F. Wahl, P.-M. Yuan, N. Arai, B. E. Pearson, K. Arai, D. Korn, J. W. Hunkapiller, and T. W.-F. Wang. 1988. Human DNA polymerase α gene expression is cell proliferation dependent and its primary structure is similar to both prokaryotic and eukaryotic replicative DNA polymerases. EMBO J. 7:37-47.
27. Zweygberg Wirgart, B., K. Claesson, B.-M. Eriksson, M. Brundin, G. Tufvesson, T. Tötterman, and L. Grillner. 1996. Cytomegalovirus (CMV) DNA amplification from plasma compared with CMV pp65 antigen (ppUL83) detection in leucocytes for early diagnosis of symptomatic CMV infection in kidney transplant patients. J. Clin. Diagn. Virol. 7:99-110.